Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Second and third line treatment in non-small cell lung cancer.

Favaretto A, Pasello G, Magro C, Schettino C, Gridelli C.

Crit Rev Oncol Hematol. 2009 Aug;71(2):117-26. doi: 10.1016/j.critrevonc.2009.01.009. Epub 2009 Feb 26. Review.

PMID:
19249227
2.

Second-line Therapy for advanced non-small-cell lung cancer.

Hann CL, Brahmer JR.

Curr Oncol Rep. 2006 Jul;8(4):243-7. Review.

PMID:
17254522
3.

Second and third line treatment in advanced non-small cell lung cancer.

Favaretto AG, Pasello G, Magro C.

Discov Med. 2009 Dec;8(43):204-9.

4.

Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer?

Gebbia V.

Expert Opin Pharmacother. 2008 Jun;9(8):1321-37. doi: 10.1517/14656566.9.8.1321 . Review.

PMID:
18473707
5.

New targets for non-small-cell lung cancer therapy.

Alvarez M, Roman E, Santos ES, Raez LE.

Expert Rev Anticancer Ther. 2007 Oct;7(10):1423-37. Review.

PMID:
17944567
6.

Second-line treatment options in advanced non-small cell lung cancer: current status.

Cullen M.

Semin Oncol. 2006 Feb;33(1 Suppl 1):S3-8. Review.

PMID:
16472703
7.

Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.

Sun JM, Lee KW, Kim JH, Kim YJ, Yoon HI, Lee JH, Lee CT, Lee JS.

Jpn J Clin Oncol. 2009 Jan;39(1):27-32. doi: 10.1093/jjco/hyn118. Epub 2008 Oct 24.

8.

New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer.

Scagliotti GV, Selvaggi G.

Clin Lung Cancer. 2008;9 Suppl 3:S122-8. doi: 10.3816/CLC.2008.s.018. Review.

PMID:
19419926
9.

Pemetrexed disodium for the treatment of NSCLC: an update.

Hsu JY, Wakelee H.

Drugs Today (Barc). 2008 Sep;44(9):669-78. doi: 10.1358/dot.2008.44.9.1250412. Review.

PMID:
19137122
10.

Second-line treatment of small-cell lung cancer.

MacCallum C, Gillenwater HH.

Curr Oncol Rep. 2006 Jul;8(4):258-64. Review.

PMID:
17254525
11.

Recent developments of targeted therapies in the treatment of non-small cell lung cancer.

Rossi A, Maione P, Colantuoni G, Ferrara C, Rossi E, Guerriero C, Nicolella D, Falanga M, Palazzolo G, Gridelli C.

Curr Drug Discov Technol. 2009 Jun;6(2):91-102. Review.

PMID:
19519336
12.

Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer.

Gérard C, Debruyne C.

Mol Oncol. 2009 Dec;3(5-6):409-24. doi: 10.1016/j.molonc.2009.09.001. Epub 2009 Sep 10. Review.

13.

Second-generation epidermal growth factor tyrosine kinase inhibitors in non-small cell lung cancer.

Mukherji D, Spicer J.

Expert Opin Investig Drugs. 2009 Mar;18(3):293-301. doi: 10.1517/13543780902762843 . Review.

PMID:
19243280
14.

Second-line treatment for advanced-stage non-small-cell lung cancer: current and future options.

Ho C, Davies AM, Lara PN Jr, Gandara DR.

Clin Lung Cancer. 2006 May;7 Suppl 4:S118-25. Review.

PMID:
16764752
15.

[Stage IV NSCLC. Biological treatments of lung cancer in 2008... and in the near future].

Bergot E, Levallet G, Zalcman G.

Rev Mal Respir. 2008 Oct;25(8 Pt 2):3S119-26. French.

PMID:
18971836
16.

[Second-line treatment and targeted therapy of advanced lung cancer].

Nakamura Y, Yamamoto N.

Gan To Kagaku Ryoho. 2009 May;36(5):710-6. Japanese.

PMID:
19461168
17.

Pemetrexed for the treatment of non-small-cell lung cancer.

Manegold C, Schmid-Bindert G, Pilz LR.

Expert Rev Anticancer Ther. 2009 Sep;9(9):1195-209. doi: 10.1586/era.09.97. Review.

PMID:
19761423
18.

[Non-small cell lung cancer - from treatment of relapse to treatments for relapses].

Souquet PJ.

Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S108-13. Review. French.

PMID:
18235402
19.

New targeted treatments in lung cancer--overview of clinical trials.

Korfee S, Gauler T, Hepp R, Pöttgen C, Eberhardt W.

Lung Cancer. 2004 Aug;45 Suppl 2:S199-208. Review.

PMID:
15552800
20.

Multitargeted inhibitors in lung cancer: new clinical data.

Bar J, Herbst RS, Onn A.

Clin Lung Cancer. 2008;9 Suppl 3:S92-9. doi: 10.3816/CLC.2008.s.014. Review.

PMID:
19419930
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk